ERBB2 and cancer: However, because almost every cancer patient displayed a nonzero AIMP2-DX2/AIMP2 expression ratio, the optimal cutoff value needs to be determined for defining AIMP2-DX2 positivity, as is the case for the her2/cep17 ratio in breast cancer35.